<DOC>
	<DOCNO>NCT02142881</DOCNO>
	<brief_summary>To date , observational intervention study define hypertension basis clinic blood pressure ( BP ) . Measurement BP outside clinic home ambulatory BP provide good estimate risk cardiovascular disease all-cause mortality . Using clinic ambulatory BPs , patient categorize normotensive ( normal clinic ambulatory BPs ) , white-coat hypertension ( elevate clinic BP normal ambulatory BP ) , mask hypertension ( normal clinic BP elevate ambulatory BP ) , sustain hypertension ( elevate clinic ambulatory BP ) . Approximately one third patient chronic kidney disease ( CKD ) normal clinic BP elevate ambulatory BP ( mask hypertension ) . We demonstrate , among participant Chronic Renal Insufficiency Cohort ( CRIC ) study , low estimate glomerular filtration rate ( eGFR ) elevate proteinuria associate increase odds mask hypertension . Additionally , participant mask hypertension increase risk target organ damage assess left ventricular mass pulse wave velocity . These result participant CKD consistent prior study patient normal renal function demonstrate two-fold increase risk cardiovascular event patient mask hypertension compare patient normal clinic ambulatory BP . Despite elevated risk adverse outcome , patient mask hypertension exclude hypertension trial normal clinic BP . Therefore , unknown whether reduction target organ damage adverse cardiovascular outcome associate treatment hypertension extend patient masked hypertension . To address important gap knowledge , plan randomize , control trial evaluate whether antihypertensive treatment modify BP pattern patient masked hypertension , , convert control clinic ambulatory BP . We also evaluate effect antihypertensive treatment target organ damage patient masked hypertension . The current study pilot randomize control trial evaluate feasibility plan trial effect antihypertensive therapy clinic ambulatory BP , proteinuria , target organ damage patient masked hypertension .</brief_summary>
	<brief_title>Treatment Masked Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Masked Hypertension</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>Age 1875 year 30 &lt; eGFR &lt; 70 ml/min/1.73m2 within 9 month screen visit Urine albumin creatinine ratio &gt; 100mg/gm OR urinalysis ≥30mg/dL albuminuria within 9 month screen visit Most recent clinic systolic BP &gt; 120 &lt; 140 mmHg within 9 month screen visit Masked hypertension screen baseline visit Clinic systolic BP &lt; 140 mmHg 24hr ambulatory systolic BP &gt; 130 mmHg Taking ≤ 2 antihypertensive medication No change antihypertensive medication past 6 month Heart failure Lightheaded standing Loss consciousness past 24 month NonEnglish speaker History breast cancer require mastectomy radiation side nondominant arm unable refuse use dominant arm ambulatory BP monitoring Cardiovascular event procedure hospitalization unstable angina within last 3 month Inability perform ambulatory BP monitoring due compliance clinical reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>